BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30165205)

  • 61. Comparable detection of HPV using real-time PCR in paired cervical samples and concentrated first-stream urine collected with Colli-Pee device.
    Nilyanimit P; Chaithongwongwatthana S; Oranratanaphan S; Poudyal N; Excler JL; Lynch J; Vongpunsawad S; Poovorawan Y
    Diagn Microbiol Infect Dis; 2024 Mar; 108(3):116160. PubMed ID: 38184985
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of Three Different Commercial Kits for the Human Papilloma Virus Genotyping.
    Lim YK; Choi JH; Park S; Kweon OJ; Park AJ
    J Clin Lab Anal; 2016 Nov; 30(6):1110-1115. PubMed ID: 27121347
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Species-level characterization of the cervicovaginal microbiota and its role in human papillomavirus-associated cervical carcinogenesis.
    Logel M; El-Zein M; Franco EL; Gonzalez E
    J Med Virol; 2024 Jun; 96(6):e29764. PubMed ID: 38923577
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison between the Roche Cobas 4800 Human Papillomavirus (HPV), Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex HPV28 Assays for High-Risk HPV Detection and Genotyping in Mocked Self-Samples.
    Bell M; Verberckmoes B; Devolder J; Vermandere H; Degomme O; Guimarães YM; Godoy LR; Ambrosino E; Cools P; Padalko E
    Microbiol Spectr; 2023 Aug; 11(4):e0008123. PubMed ID: 37284753
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of Human Papillomavirus Genotype Detection in Paired Urine and Self-Collected Cervical Swabs: A Pilot Study.
    Patel SS; Singh N; Jamwal A; Sahu C; Garg A; Rao N; Tejan N; Khan R
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2427-2430. PubMed ID: 37505776
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical validation of the cobas 4800 HPV test for cervical screening purposes.
    Heideman DA; Hesselink AT; Berkhof J; van Kemenade F; Melchers WJ; Daalmeijer NF; Verkuijten M; Meijer CJ; Snijders PJ
    J Clin Microbiol; 2011 Nov; 49(11):3983-5. PubMed ID: 21880968
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prevalence and Distribution of Human Papillomavirus Genotypes Among Women in Kinshasa, The Democratic Republic of the Congo.
    Mutombo AB; Benoy I; Tozin R; Bogers J; Van Geertruyden JP; Jacquemyn Y
    J Glob Oncol; 2019 Jul; 5():1-9. PubMed ID: 31310568
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Testing for Human Papillomaviruses in Urine, Blood, and Oral Specimens: an Update for the Laboratory.
    Poljak M; Cuschieri K; Alemany L; Vorsters A
    J Clin Microbiol; 2023 Aug; 61(8):e0140322. PubMed ID: 37439692
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Principles and analytical performance of Papilloplex® HR-HPV, a new commercial CE-IVD molecular diagnostic test for the detection of high-risk HPV genotypes.
    Sakellariou GK; Bilski M; Moreau M; Stofanko M; Liu Y; Boland E; Kapadia D; Harrison M; Fu G
    Diagn Microbiol Infect Dis; 2019 Sep; 95(1):46-54. PubMed ID: 31129006
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical vaginal-microecology testing using double-fluorescence staining in patients with high-risk human papillomavirus infection.
    Ji L; Zhang X; Zhou Y; Guo W; Wu J; Yang J
    Diagn Microbiol Infect Dis; 2024 Aug; 109(4):116342. PubMed ID: 38772053
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prevalence and genotype distribution of human papillomavirus in Czech non-vaccinated heterosexual couples.
    Jaworek H; Koudelakova V; Oborna I; Zborilova B; Brezinova J; Ruzickova D; Vrbkova J; Kourilova P; Hajduch M
    Virol J; 2021 Apr; 18(1):80. PubMed ID: 33858457
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical and analytical performance of the CLART HPV 4S assay with SurePath screening samples from the Danish cervical cancer screening program using the VALGENT framework.
    Ejegod DM; Pedersen H; Quint W; Xu L; Arbyn M; Bonde JH
    J Virol Methods; 2021 Jun; 292():114118. PubMed ID: 33766660
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical Performance of the Full Genotyping Agena MassARRAY HPV Assay Using SurePath Screening Samples within the VALGENT4 Framework.
    Pedersen H; Ejegod DM; Quint W; Xu L; Arbyn M; Bonde J
    J Mol Diagn; 2022 Apr; 24(4):365-373. PubMed ID: 35123039
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Feasibility and Accuracy of Menstrual Blood Testing for High-risk Human Papillomavirus Detection With Capture Sequencing.
    Zhang J; Tian X; Chen Y; Huang S; Cui Z; Tian R; Zeng Z; Liang W; Gong Q; Shang R; Hu Z; Cao C
    JAMA Netw Open; 2021 Dec; 4(12):e2140644. PubMed ID: 34940863
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Implementation of Multicolor Melt Curve Analysis for High-Risk Human Papilloma Virus Detection in Low- and Middle-Income Countries: A Pilot Study for Expanded Cervical Cancer Screening in Honduras.
    Turner SA; Deharvengt SJ; Lyons KD; Espinal JAP; LaRochelle EPM; Bejarano S; Kennedy L; Tsongalis GJ
    J Glob Oncol; 2018 Sep; 4():1-8. PubMed ID: 30241169
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sensitive HPV genotyping based on the flow-through hybridization and gene chip.
    Tao P; Zheng W; Wang Y; Bian ML
    J Biomed Biotechnol; 2012; 2012():938780. PubMed ID: 23193367
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of nucleic acid extraction procedures on human papillomavirus (HPV) detection and genotyping.
    Naegele K; Weissbach FH; Leuzinger K; Gosert R; Bubendorf L; Hirsch HH
    J Med Virol; 2023 Feb; 95(2):e28583. PubMed ID: 36794677
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Performance analysis of high-throughput HPV testing on three automated workflows.
    Loonen AJM; Huijsmans CJJ; Geurts-Giele WRR; Leeijen C; van der Linden JC; van den Brule AJC
    APMIS; 2020 Aug; 128(8):497-505. PubMed ID: 32562292
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tobacco Use and Prevalence of Human Papillomavirus in Self-Collected Cervicovaginal Swabs Between 2009 and 2014.
    Tarney CM; Beltran TA; Klaric J; Han JJ
    Obstet Gynecol; 2018 Jul; 132(1):45-51. PubMed ID: 29889765
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Human Papillomavirus Prevalence Among American Indian Women of the Great Plains.
    Lee NR; Winer RL; Cherne S; Noonan CJ; Nelson L; Gonzales AA; Umans JG; Buchwald D;
    J Infect Dis; 2019 Feb; 219(6):908-915. PubMed ID: 30321371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.